All lobbying filings
Alston & Bird LLP
Alston & Bird LLP filed a Q3 report for Ossium Health, Inc. on October 20, 2026, reporting $70,000 in lobbying income.
Lobbying for Ossium Health, Inc. · Bioengineering Company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
4
Lobbying activity
1
Advancing contract and other partnership opportunities for Ossium.